FDA death data on kratom linked to adulterated products, not the kratom plant itself
“The FDA appears to be deliberately violating the provisions of the Information Quality Act by widely disseminating incomplete, inaccurate, biased, and unreproducible information to local medical examiners and coroners, incorrectly blaming kratom for deaths that were actually caused by polydrug use or deliberately adulterated kratom products.”
NIDA’s conclusion following its extensive review of whether a person can overdose on kratom clearly documents that pure or natural kratom does not present a public health risk under the criteria for scheduling set by the CSA, and the FDA already has ample statutory authority to seize all dangerous adulterated and counterfeit products. “There is not a single instance in the history of DEA scheduling where a substance was banned because it had been deliberately adulterated with a separate deadly drug,” wrote Dave Herman, Chairman of the AKA, in a letter to Assistant Secretary Giroir, calling upon HHS to formally request the recall of the kratom scheduling recommendation from the DEA. “Congress never intended for the Controlled Substances Act (CSA) to be used to ban substances that were deliberately adulterated with other toxic or deadly drugs that cause deaths, and nothing in the statute or the legislative history permits this abuse of discretion in the scheduling recommendation initiated by the FDA.”
Original Article (PR Newswire):
FDA death data on kratom linked to adulterated products, not the kratom plant itself
Artwork Fair Use: ECfES Public Lending Library : Encyclopedia of Psychoactive Plants
